Leiomyosarcoma clinical trials at UCSF
1 research study open to eligible people
Leiomyosarcoma is a type of cancer that develops from smooth muscle tissue. UCSF is comparing a study drug combined with chemotherapy to a placebo combined with the same chemotherapy. The trial is for people with advanced or metastatic leiomyosarcoma who have been treated before.
Showing trials for
ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)
open to eligible people ages 18-99
To compare the efficacy and safety in subjects with advanced or metastatic LMS previously treated with an anthracycline.
San Francisco, California and other locations
Our lead scientists for Leiomyosarcoma research studies include Varun Monga, M.D.
Last updated: